east-large-B.png
 

7.10.19

The Board Meeting series is designed to open minds and explore new trends that will translate into more effective governance and success throughout the life science industry.  The Board Meeting is an exclusive, invite-only, off the record meeting for life science CEOs and board members to discuss key issues and solve problems in an interactive and productive setting.

east-top-banner.jpg

SPONSORS

 
 

SPONSORSHIP OPPORTUNITIES

Sponsors gain access in an intimate and private setting with life science industry top leaders and decision makers.

For additional information, please contact Susan Grayson at susan@crushlifesicences.com or sponsor@crushlifesciences.com.


HILIGHTS from the BOARD MEETING 2018:

DRAFT AGENDA based on the 2018 meeting

8:00 – 8:45 am                          
Registration and Networking Breakfast

8:45 – 9:00 am                          
Welcome and Opening Remarks

9:00 – 10:30 am
Keynote - Best Practices for Successful and Productive Board Meetings: Ram Charan, Leading International Business Advisor and Author

10:30 - 11:00 am
Networking Break                  

11:00 - 11:45 am
Building the Right Board:  Walter Ogier, Executive Chairman, Anelixis Therapeutics and Ellen Zane, CEO Emeritus & Vice Chair, Board of Trustees, Tufts Medical Center
Moderator: Laurie Halloran, President, Halloran Consulting Group

11:45 - 12:15 pm
Assessing the China Factor when Fund Raising:
Carl Firth
, Founder & CEO, ASLAN Pharmaceuticals and Peter Wirth,
Chairman, Syros Pharmaceuticals and Director and Senior Advisor, Zai Lab

12:15 - 1:15 pm              
Networking Lunch with Breakout Sessions

Managing a Down Round in a Private Company: Chris Ehrlich, Managing Director, Locust Walk and Steve London, Partner, Pepper Hamilton LLP

Activist Investors and Boards: Ram Charan, Leading International Business Advisor and Author and Jim Mullen, former CEO, Biogen Idec and Chairman, Editas Medicine

 

 

1:15 - 2:00 pm
Managing Inexperienced and Dysfunctional Directors: Karen Dawes, President, Knowledgeable Decisions and Board Chair, Repligen Corporation and John Richard, Co-Founder and Head of Corporate Development, Mereo Biopharma
Moderator: Denise DeMan, Chairman & CEO, Bench International

2:00 - 2:45 pm                        
The Board's Role in Change: Chris Earl, President, Innotrove and Senior Advisor, International AIDS Vaccine Initiative; Marc Goldberg, Managing Director, BioVentures Investors; Mary Ann Gray, President, Gray Strategic Advisors

2:45 – 3:15 pm                         
Networking Break

3:15 – 4:00 pm
Dual Sessions         

The Board's Role in Crisis Management:
Tom Hughes, President & Chief Scientific Officer, Zafgen and Paris Panayiotopoulos, Operating Partner, Clarus Ventures and former CEO, ARIAD Pharmaceuticals
Moderator: Doug MacDougall, Managing Partner, MacDougall Biomedical Communications

Beyond the Crossover Round: Rethinking the IPO Process - Introducing the "Series I" IPO:
Peter Kolchinsky
, Managing Director, RA Capital Management and Maren Winnick, Managing Director, Evercore
Moderator: Bill Hicks, Co-chair, Securities & Capital Markets Practice Group, Mintz Levin

4:00 - 5:00 pm
Keynote and Closing Remarks: Jay Lorsch, Louis E. Kirstein Professor of Human Relations, Harvard Business School
Moderator: Doug MacDougall, Managing Partner, MacDougall Biomedical Communications

5:00 - 6:00 pm
Networking Cocktail Reception

 

crush-background.jpg

KEYNOTE SPEAKERS

portrait-ram.jpg
 

Ram Charan

Ram Charan is a world-renowned business advisor, author and speaker who has spent the past 35 years working with many top companies, CEOs, and boards of our time. In his work with companies including GE, MeadWestvaco, Bank of America, DuPont, Novartis, EMC, 3M, Verizon, Aditya Birla Group, Tata Group, GMR, Max Group, Yildiz Holdings, and Grupo RBS, he is known for cutting through the complexity of running a business in today’s fast changing environment to uncover the core business problem. His real-world solutions, shared with millions through his books and articles in top business publications, have been praised for being practical, relevant and highly actionable — the kind of advice you can use Monday morning.

 
portrait-jay.jpg
 

Jay W. Lorsch

Jay W. Lorsch is the Louis Kirstein Professor of Human Relations at the Harvard Business School. He is editor of The Future of Boards: Meeting the Governance Challenges of the Twenty-First Century (2012) He is the author of over a dozen books, the most recent of which are Back to the Drawing Board: Designing Boards for a Complex World (with Colin B. Carter, 2003), Aligning the Stars: How to Succeed When Professionals Drive Results (with Thomas J. Tierney, 2002), and Pawns or Potentates: The Reality of America's Corporate Boards (1989). Organization and Environment (with Paul R. Lawrence) won the Academy of Management's Best Management Book of the Year Award and the James A. Hamilton Book Award of the College of Hospital Administrators in 1969